DatasetName,PAG1_S(229) PAG1_S(239) PAG1_S(288) PAG1_S(292) PAG1_S(293) PAG1_S(295) PAG1_S(298) PAG1_S(301) PAG1_S(354) PAG1_S(50) PAG1_Y(227),PAG1_S(150) PAG1_S(171) PAG1_S(201) PAG1_S(296) PAG1_S(351) PAG1_S(353) PAG1_S(61) PAG1_T(287) PAG1_Y(163) PAG1_Y(359) PAG1_Y(417),PAG1_S(249)
RM2024_Intensity D4-1___3,0.5477040488998915,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,0.5580228410702429,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,0.6041407563608187,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,0.46813179569919555,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.5732099479799324,,
HS2024_6_B_T3,0.5745313672778871,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,0.5383384929174664,,
FSO2013_Ratio M/L normalized Rep1,0.5816308234325288,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.5599207589390578,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.5695671281569831,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,0.48341490751086796,,
FSO2013_Ratio M/L normalized Rep1___1,0.5816051374834652,,
SAS2015_AZD/DMSO_Exp3,0.5685958769327839,0.4602516904253556,
RM2024_Intensity D0-2___3,0.567841218666561,,
RM2024_Intensity D6-1,0.5673162627192296,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,,,
WZ2023_Pu_010_30min,,,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,0.563505779457165,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.5673556263077085,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,0.5551880487499412,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,0.5622603356677038,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.5581049737894999,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),0.5416946085143355,,
UK2020_HCM_2,,,0.266102050824328
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,,
RM2024_Intensity D4-3___3,0.5556684639901669,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,0.6066675695223165,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,0.5772990926527171,,
RM2024_Intensity D6-2___3,0.5590661920334875,,
WZ2023_Pe_025_10min,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,0.5625637784085096,,
WZ2023_Pu_005_10min,,,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.5648624734317392,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,,,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,0.585614576446961,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,0.5507966525270482,,
CR2017_Ratio Replicate 1.4,0.5265679602565982,0.447372947578672,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,,
CR2017_Ratio Replicate 1.3,0.5168070606529165,0.4687988323749263,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,0.5589030230203647,,
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,0.5519020902918521,,
FSO2013_Ratio H/L normalized Rep1___1,0.5711263459367387,,
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,0.4697547894313883,
HS2024_3_B_N1,0.5811648231423867,,
RM2024_Intensity D4-2___3,0.5570144024036225,,
WZ2023_Pe_025_30min,,,
CK2022_11 40-1,0.5644949741023894,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,,
FSO2013_Ratio H/L normalized Rep2,0.5670495210009483,,
WZ2023_Pu_005_20min,,,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.5316749295711144,0.4428495841605822,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,0.5548157131732253,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,0.560960999972237,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,0.5841788344104484,0.4884489160614715,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,0.567302264949621,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,0.6496316973107998,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,0.464978498369844,
CK2022_1 200-1,0.5728251547306633,0.4701926753852734,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,0.559773555255796,0.46810222796572415,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,,,
RCJD2014_5min_1,0.6024403191781129,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,0.563131471420492,0.48876344971899877,
CR2017_Ratio Replicate 3.3,0.5717116493582837,,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.5775794737389517,,
KBE2022_Log2_Ex_8_T,0.5643406049555323,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,0.554337921567098,0.46338486651276134,
RN2012_L11,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,0.6007777868273444,0.47249873136488996,
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,0.5474857162601838,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,0.552551355747548,,
YA2020_Reporter_intensity_Cancer_No.5,0.5770952757859376,0.47165017351151256,
HH2022_Reporter intensity 8,0.56529838360622,,
ZQ2022_N2,0.5687246599130693,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.56997212128214,,
EJN2021_5_Rest_Basal,,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,0.5662999171062294,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,0.5625357833941117,0.4693012896434798,
HS2024_3_B_T1,0.6023005857179291,0.48850908563058865,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,0.581264038207041,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,0.5246629768648643,0.45592172610662546,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.6018752555481649,,
HS2024_8_I_T3,0.49120091896808765,,
CF2017_EOC 3,0.5500614566089788,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,0.5678670920527669,0.48406677507255264,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,,,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.549121514566006,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,0.4670509101826422,
KS2014_Intensity N3,,,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,0.5750018430298597,,
RAM2015_Log2 A,,,
HS2024_8_PD_T1,0.5158910777200015,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,0.5613317392812565,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,0.5417157186622,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,0.5798112296111477,,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,0.47179653505528923,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,,
HS2024_6_B_N1,0.5514983404074539,,
KBE2022_Log2_Ex_27_T,0.5557468344255478,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,0.558575949505459,0.47283524185889264,
AMK2021_120R_p5,0.5522461188944242,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,0.5790787305899808,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,0.5684105261177301,,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,0.5568719412499301,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.5620365694196452,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,,
EJN2021_4_Rest_Ins,,,
RN2012_H05,,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.5425791705998981,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,,
HH2022_Reporter intensity 3,0.5648203157757942,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,,
JW2021_After_3,,,
GF2025_P8_Sph,0.5488186150075479,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,0.5759070178615671,0.4891498846192322,
CK2022_12 200-1,0.5738520926307212,0.4805904821652739,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,0.5494538207065247,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.5522104593126493,,
WZ2023_Su_010_20min,,,
AH2018_TMTMS2_2_N,0.5685099459433993,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.5666644565476479,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,
AH2018_TMTMS3_Pool,0.571935650524168,,
KS2014_Intensity N4,,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,0.5724528540908259,0.47815482946637394,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.5713628998597122,,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,0.4719846462383177,
GF2025_P1_Adh,0.5450151909872992,,
GF2025_P1_Sph,0.5783464190805822,,
EJN2021_5_Ex_Basal,,,
HS2024_7_I_T3,0.5252364099103458,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,,,
CF2017_EOC 1,0.5431506235963259,,
CK2022_3 200-1,0.5736127151451597,0.46847093082312197,
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5465135807900802,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,0.5476404069617348,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,0.5343527873418331,0.4806442194805942,
HS2024_5_B_T1,0.5701331606011175,0.4713864606067539,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,0.5778914487140456,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,0.5457372427513362,,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.5708198824200266,0.4689255126606681,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,0.4674626473217293,
AR2021_ALG 1 μM,0.5834457031657101,,
HS2024_4_B_T1,0.5514206680579828,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,0.573748880644282,,
CR2017_Ratio Replicate 3.2,0.604488632907816,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.5102540768676996,,
CK2022_9 16-1,,0.48155558627267414,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,0.5512030509593031,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,0.5800878065087879,,
KS2014_Intensity pY_N4,0.5519191842034048,,
CK2022_13 200-1,0.5758663660635158,0.48056076692432087,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,,0.4701182016545938,
FS2019_db/db3,,,
CK2022_15 40-1,0.558098713077246,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.5658783485263992,,
AMK2021_Ctrl_p1,0.540807376258016,,
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,0.6035853674157872,0.47476440891997806,
AH2018_TMTMS3_3_X,0.5721696571201839,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.567667149872814,,
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,0.5619660939362139,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,0.5636605902833893,0.4691481282970605,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,0.5612981908481455,,
CK2022_12 16-1,,0.4763563591112126,
RN2012_L13,,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,0.5449090654329439,,
KBE2022_Log2_Ex_8_U,0.561988106971043,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,0.5750602753737,0.484415887625998,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,0.5664796646311772,,
HS2024_6_I_T2,0.5407329111613832,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.5770751447423458,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.5638987589206367,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,0.5595658258214189,,
LY2019_P3+,0.5562736208684617,,
HH2022_Reporter intensity 6,0.5605775262782018,,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,0.5830745527399324,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.5673038066983472,,
GF2025_P3_Adh,0.5343395467837865,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,0.5686049856998179,,
RM2024_Intensity D0-1___2,0.5810345883815088,,
LY2019_P4+,0.543654768607358,,
KBE2022_Log2_Ex_19_U,0.5653528019648223,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.5838730985087924,0.4626772263241785,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,0.5481234069696936,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.5787184562263887,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,0.5610168787291914,0.4696949910979798,
HS2024_8_B_T2,0.5326717285448672,0.45489370464912854,
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,0.5675744679964875,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,,
HH2022_Reporter intensity 1,0.5645549428709096,,
HH2022_Reporter intensity 2,0.5648941868518785,,
RM2024_Intensity D6-2___2,0.5439687939109963,0.47824421677077633,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,0.554923083646063,,
YA2020_Reporter_intensity_Normal_No.5,0.5716133414215441,0.4699386092074063,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,0.5203663377004487,0.4633365774264541,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,,,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,0.5614974076346033,0.47955392293626925,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.5834616660300945,,
AR2021_KD 72h,0.5573211404754841,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.550443956306378,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.573914141979346,,
KBE2022_Log2_Ex_9_U,0.5236239053506938,,
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,0.5650238333878258,,
RM2024_Intensity D0-3,0.5811016748229404,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,0.5431284700781623,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,0.5321668119070119,,
PG2020_Intensity 10h_A,,,
RN2012_L12,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,0.5839622984429013,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,0.5685864463190946,,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.5383895428044657,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.5478696230202106,,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,,
TM2022_S2.12h.B,,,
RN2012_L15,0.5392024338447087,0.4764947525116126,
KS2014_Intensity pY_PV3,0.5663560158061639,0.4753441321837601,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.5680787125993929,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,0.5564254723064332,0.4636651521243801,
CK2022_7 200-1,0.5742277537092938,0.4717734124992741,
CK2022_5 200-1,0.5739762786389876,0.4711748935595122,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,0.5673812852966922,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,0.571087587920869,,
KBE2022_Log2_Ex_25_U,0.5643323826632226,,
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,0.5669557795276124,,
CK2022_4 16-1,,0.4657247160176517,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,0.5849161416045828,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,0.5589247142364312,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,0.5714625905238485,,
KBE2022_Log2_Ex_9_T,0.5255709043700474,,
AH2018_SILAC_IT_2_N,,,
AH2018_SILAC_IT_1_X,,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,0.5425983722634622,,
UK2020_UA_2,,,0.1630681747583592
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.5721359703173015,,
WZ2023_Pe_025_20min,,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,0.6148995656037727,0.486130926649838,
AH2018_TMTMS2_3_N,0.567304024817274,,
RN2012_H06,0.5793629354384239,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,0.6515246382974728,,
WZ2023_Su_005_30min,,,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,0.2387090594696369
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5328282318677013,0.4633861326695736,
WZ2023_Su_025_10min,,,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,0.5559460909514714,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,0.5637962994680439,0.4762950684702979,
WZ2023_Su_005_20min,,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,0.5553662155255895,0.4465259086346979,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,0.5374110267847487,,
EP2017_Untreated R#1 normalized log2 ratio,,,
RN2012_L10,,,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,0.5696042008458592,,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,,,
HS2024_4_B_T3,0.5714542415507864,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,0.5779692936994094,0.47148383195794613,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,0.5334193850852643,0.4591781148443369,
KBE2022_Log2_Ex_6_U,,0.4723492329674185,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.5339482078884985,0.4692882062382706,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.5755351152940729,0.4771137261161544,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,,
GF2025_P9_Sph,0.6134755245269934,,
CK2022_6 200-1,0.5719288163247498,0.4709418080638136,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.5756776996872933,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,0.5842598089188054,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,0.471650323007309,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,0.5840390100341517,,
SAS2015_AZD/DMSO_Exp1,0.5606987374125326,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,0.5972324669692719,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.5717450387747207,0.4700917252527544,
KS2014_Intensity pY_C4,0.5667945206071627,,
CR2017_Ratio Replicate 3.5,0.5429244203598332,0.5314739414351256,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,0.5697694634288335,0.474420699134882,
RM2024_Intensity D4-3___2,0.5776128302377503,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,0.5452411943205354,,
KBE2022_Log2_Ex_29_T,0.5473409568139497,,
HS2024_7_I_T2,0.532537803622701,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,0.5846917787318492,,
AMK2021_45I_p5,0.544017239131652,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,0.5703375747902141,0.47537571127098366,
EJN2021_1_Ex_Basal,,,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,0.564631828363764,0.4767228682287951,
KBE2022_Log2_Ex_39_U,,0.47109641873953356,
EP2017_Untreated R#3 log2 ratio,,,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.5217925859310708,0.5210774480531911,
HS2024_8_PD_T2,0.540045685266639,0.4587313923871709,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,0.560228641781277,,
HS2024_8_B_N1,0.5561015546643955,0.4765298872037016,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,0.47808843450630234,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,0.5454681803350443,0.4559473817050439,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5512078496801235,,
YA2020_Reporter_intensity_Normal_No.2,0.5674183550480391,0.4667750832622554,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,0.616136534569431,,
HS2024_3_PD_T3,0.6045241142853783,,
AMK2021_120R_p3,0.5616537071340074,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.568499978951879,,
CK2022_2 16-1,,0.4676034968446146,
RAM2015_Log2 B,,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,0.5600304002939958,,
HS2024_6_B_T1,0.5871493074943445,,
UK2020_HCM_5,,,0.2103009772719756
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,0.5602426367202372,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,0.4929782358561284,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,,,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,0.5771277106217599,0.46048650364583793,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,0.5760598359049278,0.4754984169650236,
AMK2021_Ctrl_p3,0.5506115390592701,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,0.5672221057586726,,
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,0.5593157626705656,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.5734512443329273,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,0.5581185710198421,0.47398516048871353,
HS2024_5_I_T2,0.609945420080616,0.4719408112115007,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.5743654647006691,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,,,
RM2024_Intensity D0-1,0.572553049074052,0.463931440113841,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.5297392732010064,,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,0.5501784807711815,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,,,
GF2025_P3_Sph,0.5517852065581962,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.6113796493860781,0.46068350453861595,
ZQ2022_N1,0.5666272206637474,,
LY2019_P6-,0.5593840052769528,,
RM2024_Intensity D2-3,0.5794316444106767,,
UK2020_HCM_1,,,0.2137878459128352
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,0.5611404690440611,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5337200327480233,0.46337231757167774,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,0.207459644980222
KBE2022_Log2_Ex_13_U,0.5638749314414034,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.5476068655996316,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,0.5705339408802936,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,0.6070416574520963,0.47389483798340937,
WZ2023_Su_025_20min,,,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,0.5520256512065417,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,0.5688004426611303,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.5578603811054671,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,0.6381690037318156,,
EJN2021_4_Ex_Ins,,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,,
EP2017_Pervanadate R#3 log2 ratio,,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,0.5120979542193802,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,,
CK2022_6 40-1,0.5476619583639012,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,0.47369144588402146,
LY2019_P3-,0.5578532198613443,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,,,
HS2024_8_PD_T3,0.5033219888002309,0.45229447832859027,
EJN2021_3_Ex_Basal,,,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,,,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.5427882344587244,,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,0.603331793043994,0.4765136506666848,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.5683070423771613,,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.573111881820984,,
HS2024_8_I_N2,0.5698793631759332,0.47767257566166105,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,0.5661735308726686,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,0.5634006069121662,0.46022825375617615,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,0.5651588935598254,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,0.4707252617803677,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.5491949377412719,,
LY2019_P2-,0.5768892487992893,,
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,,,
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,0.5366305773921373,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,0.607592799450989,0.48131836357906876,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.5495681209694184,,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,0.57286731271041,0.475169235040935,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,0.558166842852456,,
HS2024_5_B_T2,0.6097324025726891,0.4789499953168137,
HS2024_6_I_T1,0.5377385775201996,,
HS2024_5_B_T3,0.6007428326804554,0.4741344032094117,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.5987831199492253,,
AH2018_TMTMS3_3_N,0.5706631001311057,,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,,
KBE2022_Log2_Ex_36_T,0.5828615829496516,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,,,
KS2014_Intensity C2,,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,0.5458611773925577,,
KBE2022_Log2_Ex_42_T,,0.47147586849311884,
CK2022_9 200-1,0.577876568450628,0.4887083953637076,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.5799947660992932,0.487688719560095,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,0.5374101535779263,0.4716497475000145,
RBK2021_1332T Late,,,
LY2019_P1-,0.5824805163433501,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.5701805776012637,0.46574224022529864,
HS2024_3_I_T3,0.5870375730079016,0.4857377793295857,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,,
ZQ2022_C3,0.5533900389178074,,
EJN2021_3_Rest_Ins,,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,0.47033841669663284,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,0.5572983640838508,,
EP2017_Untreated R#1 log2 ratio,,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,0.5586222083971719,,
WZ2023_Pu_010_10min,,,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,0.5779558812631489,0.47488842979707846,
KS2014_Intensity N1,,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.5473167852826131,0.4981010565990125,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,0.5599476789450385,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,,
HS2024_5_B_N2,0.6039164992216614,0.4765082434027452,
HS2024_5_I_N1,0.5923754490562735,0.47921470529042376,
HS2024_6_I_N1,0.5615148064251193,,
AR2021_KD 48h,0.5579676916975198,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,0.5568707473518427,0.4767247830285932,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,0.5602528218772658,,
WZ2023_Pe_005_10min,,,
KBE2022_Log2_Ex_29_U,0.5573448254382859,,
HS2024_7_B_T1,0.557936613767708,,
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,0.5752714087851074,0.47897331118234304,
RM2024_Intensity D4-1___2,0.5806813824267862,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,0.5646213028180264,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,0.5742474203696828,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.5706826816428504,0.4672488930037375,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,,,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,
KS2014_Intensity pY_E5_3,0.5656485834448878,0.47128597079600837,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,,
HS2024_8_B_T3,0.5179081728366363,0.47261474991426833,
YA2020_Reporter_intensity_Cancer_No.3,0.5658224331099482,0.469126422059214,
KBE2022_Log2_Ex_44_U,0.5657148817457694,,
WZ2023_Pe_010_20min,,,
KS2014_Intensity pY_C6,0.573370892488937,0.47865594397098227,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,0.5694574557918697,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,0.5843299992516523,,
KS2014_Intensity C1,,,
FSO2013_Ratio H/M normalized Rep3___1,0.5833546405821605,,
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,0.5504294320192648,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,0.47210263362101607,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,,,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,,
VOI2024_0.1uM 24 h_2 mono,0.5588247989565484,,
AH2018_TMTMS2_3_C,0.5685034854849081,,
CK2022_15 16-1,,0.4707018635721282,
CK2022_3 16-1,,0.46422368255526414,
LY2019_P4-,0.5655475814553902,,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,0.5615301248788426,0.47143849157569906,
HS2024_3_I_N2,0.5803555336568078,,
GF2025_P8_Adh,0.5192986314109245,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.5541660198342329,,
CK2022_10 16-1,,0.48225372735647826,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,0.5574359355241376,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,0.2205778356689968
SAS2015_AZD/DMSO_Exp2,0.5837457065148939,0.47044112175182895,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,,
EJN2021_2_Ex_Basal,,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,0.5563660920757421,,
AR2021_L41 10 μM,0.5675148629899254,,
CF2017_EOC 2,0.5485682372206836,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,0.2930874004542154
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,0.6254198897858659,,
CK2022_6 16-1,,0.4671182950667466,
ZX2022_CB treated Replicate 1,0.576215430830413,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.5662675049864351,,
RM2024_Intensity D2-2___2,0.5656618909647583,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.5697933057595889,,
AR2021_L41 1 μM,0.5579976078915793,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.5690009699375975,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.5784220543375441,,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.5213368474039666,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,0.6016250641982539,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,0.5739514928426946,,
SAS2015_PLX/DMSO_Exp3,0.5933591267703341,0.4608497112126915,
AMK2021_Ctrl_p5,0.5458860868932568,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.569905381129392,0.4703455870974984,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,,,
WZ2023_Pu_025_10min,,,
RM2024_Intensity D2-2___3,0.5608738112406216,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,0.5475400834651363,,
FSO2013_Ratio M/L normalized Rep3___1,0.5579210557948701,,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,0.5671065662168862,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,,,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,,,
ZQ2022_N3,0.5763557255771691,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.5620584291353676,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.5819594002059097,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.5560294339527151,,
AH2018_SILAC_IT_2_C,,,
CK2022_5 40-1,0.5460685810497197,,
AH2018_LFQ_3_X,,,
UK2020_UA_3,,,0.237074065504327
LY2019_P7-,0.5421042115245128,,
GF2025_P5_Adh,0.5400194595064517,,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.5591537831652902,,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,0.519753610561742,0.4618491915511246,
VOI2024_0.1uM 2 h_1 mono,0.5587297485120559,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,0.48145988307233695,
ZQ2022_C1,0.5571475152228221,,
CR2017_Ratio Replicate 2.1,0.5787096498101094,0.5046654460922614,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,0.5677071865813509,0.4689935846275436,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,0.5419785401212063,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,0.5425747417857631,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,0.5786865118985894,0.4721916094591087,
KS2014_Intensity pY_E5_2,0.567003993873893,0.4705937067935047,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.561583482866062,,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,0.5655094525621064,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,0.47239744177359283,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.5665465879588797,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,0.5202073864596106,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,,,
AH2018_TMTMS2_1_X,0.5684351754524146,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,,
HS2024_6_I_N2,0.5479995250181884,,
HH2022_Reporter intensity 4,0.5626840866311723,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,0.5446391197828236,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,
HS2024_4_I_T3,0.5604504970119168,,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,0.5716518727634757,,
CF2017_FTE 14,0.5565537993375421,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,0.5568496468851776,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,0.5650112455964464,,
EP2017_Untreated R#2 normalized log2 ratio,,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,0.5862915730670468,,
HS2024_5_I_N2,0.5796037232571484,0.4702137704280787,
SAS2015_PLX/AZD_Exp3,0.586267709055193,0.48125976632997197,
EP2017_Pervanadate R#2 log2 ratio,,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
